Gilead’s $2,340 price for coronavirus drug draws criticism

Source: Marilynn Marchione, Associated Press

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. 

The price was swiftly criticized; one consumer group called it “an outrage” because of the amount taxpayers invested toward the drug’s development.

Read Full Article: Gilead’s $2,340 price for coronavirus drug draws criticism

 

Tags/Keywords

 

Search

Quick Menu

Facebook FTwitter T
 

Consumer Help Desk

Advocacy